Tesamorelin / Ipamorelin

Tesamorelin 12 mg / Ipamorelin 2 mg (Phoenix)

Product Description Tesamorelin 12 mg / Ipamorelin 2 mg Blend is a research combination of a growth hormone-releasing hormone (GHRH) analog and a selective growth hormone secretagogue. Supplied as ≥98% pure lyophilized powder (HPLC/MS verified), this blend is designed for laboratory studies on synergistic growth hormone (GH) release, metabolic regulation, body composition, and tissue recovery.

Key Research Mechanism Tesamorelin activates GHRH receptors in the pituitary to stimulate endogenous GH synthesis and pulsatile release. Ipamorelin selectively binds to ghrelin/growth hormone secretagogue receptors (GHSR-1a), amplifying GH secretion with minimal effect on cortisol or prolactin. Together, the dual pathways may produce synergistic increases in GH and IGF-1 levels, enhancing metabolic and anabolic signaling in research models.

Primary Research Areas

• Synergistic growth hormone release and pituitary function studies
• Body composition, visceral fat reduction, and lipid metabolism research
• Muscle growth, recovery, and lean mass preservation
• Bone density, wound healing, and age-related metabolic pathway investigations

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.